Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles

Clinical trial NCT02015663 · TERMINATED

Trial details

NCT number: NCT02015663
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2014-01-01
Primary completion: 2014-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.